Oxygen therapy can help people with COPD breathe better and do daily activities with less difficulty. There are three types of oxygen therapy: compressed oxygen cylinders, liquid oxygen, and oxygen ...

The maintenance inhalers available for obstructive lung disease are long-acting beta-agonists (LABAs), long-acting muscarinic antagonists (LAMAs), and inhaled corticosteroids (ICSs). We use all three ...

The findings provide further support of recommendations in the clinical guidelines to favor one therapy over the other. Patients with chronic obstructive pulmonary disease (COPD) being treated with ...

Effective treatment often requires you to take medications to better manage symptoms or stop taking medications if a doctor advises that you no longer need them. Finding the right dosages and ...

Triple therapy for COPD, vs ICS/LABA therapy, was independently associated with ischemic heart disease, heart failure, arrhythmia, and atrial fibrillation/flutter. Cardiovascular events in patients ...

Managing COPD on a fixed income can be financially straining. Discover options, Medicare Extra Help, and nonprofit resources ...

AJMC®: How is COPD definitively diagnosed in clinical practice, and how does this disease create a clinical burden on patients and caregivers? Dr Rali: COPD diagnosis requires both clinical context ...

Triple therapy in COPD significantly improves lung function vs LAMA monotherapy, LABA/LAMA, and ICS/LABA, although evidence showing this is often low quality. Triple therapy is likely effective, safe, ...

Many patients with chronic obstructive pulmonary disease (COPD) have uncontrolled disease despite appropriate use of triple therapy. These patients often exhibit type 2 inflammation, as indicated by ...

Grace Anne Dorney Koppel, wife of Ted, the longtime anchor of ABC News' Nightline, has been bringing more awareness to COPD, ...

Now, molecular biologist Yohei Kirino, Ph.D. and lung disease expert Deepak Deshpande, Ph.D. have teamed up in a new study to discover a molecular smoking gun behind the rise of cytokines in COPD. The ...

In May, we reported on positive phase III trial data on dupilumab (Dupixent) for uncontrolled chronic obstructive pulmonary disease, a condition with no approved biologic therapy. In this report, we ...